Clear Harm From Aspirin-Anticoagulation Combo
Few results are more definitive than the decidedly negative AQUATIC trial of aspirin plus anticoagulation vs anticoagulation alone…
Time to Ditch FDA Warning?
Older women using vaginal estrogen tablets do not face an increased risk for recurrent ischemic stroke, a finding…
Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape
Rivaroxaban or Combo Therapy: A Winner for All Ages? MedscapeRivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary Artery…
PCPs Guide to Prescribing Blood Thinners for AF
As a primary care physician (PCP), you’re often the first healthcare professional that will identify cardiac issues, including…
GLP-1 RAs Protective Against Stroke, Neurodegeneration?
TOPLINE: Use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs), particularly semaglutide and tirzepatide, was associated with a…
Anticoagulants in AF Post-ICH: The Dilemma Continues
TOPLINE: In patients with atrial fibrillation (AF) with a recent episode of intracranial hemorrhage (ICH), the use of…
APOE4 May Raise Brain Bleed Risk in Apixaban Users With AF
TOPLINE: Carriers of the apolipoprotein E epsilon 4 (APOE ε4) allele had a threefold higher risk for intracranial…